Thrombocytopenic purpura can affect growth and development. Thrombocytopenic purpura, or thrombocytopenic purpura, includes immune and thrombotic thrombocytopenic purpura. 1. Immune thrombocytopenic purpura is mainly manifested as skin bleeding, accompanied by nasal and gum bleeding, and in severe cases, it can be accompanied by intracranial hemorrhage and internal hemorrhage, therefore, if not treated in time, it will seriously jeopardize the child’s health and growth and development. The main therapeutic drug is glucocorticoid (prednisone), long-term use will lead to osteoporosis, ischemic necrosis of bone, which will affect growth and development. 2. Thrombotic thrombocytopenic purpura is mainly characterized by bleeding, headache, visual impairment, yellowing of the skin and sclera, which can lead to kidney damage in severe cases. The condition is critical, plasma replacement therapy is preferred, and drug treatment is based on immunosuppressants, such as azathioprine, which will affect growth and development if used for a long time. If thrombocytopenic purpura occurs, it is recommended to go to the hospital in a timely manner, under the guidance of the physician early formal treatment.